Gap finder

Search review questions

Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.

Limit to evidence status or GRADE (optional)

1,361 questions in 120 reviews · Developmental, Psychosocial and Learning Problems

current versions
No studies 286 · 21%Ungraded 61 · 4.5%Very low 381 · 28%Low 381 · 28%Moderate 228 · 16.8%High 24 · 1.8%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

QuestionEffectEvidenceStatus / GRADE
BoNT‐A vs serial casting
Range of motion (ankle dorsiflexion) · children with CP
Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy (2019) · Cochrane
no estimate extracted1 study · 18 participantsLow
BoNT‐A vs serial casting
Satisfaction (not measured) · children with CP
Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy (2019) · Cochrane
no estimate extractedNRNo studies
BoNT‐A vs serial casting
Spasticity (ankle plantarflexors) · children with CP
Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy (2019) · Cochrane
no estimate extracted1 study · 18 participantsLow
BoNT‐A vs serial casting
Adverse events · children with CP
Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy (2019) · Cochrane
RR 0.59 [0.03, 11.03]3 studies · 64 participantsLow
BoNT‐A vs usual care or physiotherapy
Satisfaction (not measured) · children with CP
Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy (2019) · Cochrane
no estimate extractedNRNo studies
BoNT‐A vs serial casting
Instrumented gait analysis (peak ankle dorsiflexion in stance) · children with CP
Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy (2019) · Cochrane
no estimate extracted3 studies · 61 participantsLow
BoNT‐A vs serial casting
Observational gait analysis · children with CP
Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy (2019) · Cochrane
no estimate extracted1 study · 18 participantsModerate
BoNT‐A vs serial casting
Function · children with CP
Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy (2019) · Cochrane
no estimate extracted2 studies · 41 participantsModerate
BoNT‐A vs serial casting
Range of motion (passive ankle dorsiflexion) · children with CP
Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy (2019) · Cochrane
no estimate extracted3 studies · 67 participantsLow
BoNT‐A vs serial casting
Satisfaction (not measured) · children with CP
Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy (2019) · Cochrane
no estimate extractedNRNo studies
BoNT‐A vs serial casting
Spasticity (ankle plantarflexors) · children with CP
Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy (2019) · Cochrane
no estimate extracted3 studies · 67 participantsLow
BoNT‐A vs serial casting
Adverse events · children with CP
Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy (2019) · Cochrane
no estimate extractedNRNo studies
BoNT‐A vs serial casting
Instrumented gait analysis (peak ankle dorsiflexion in stance) · children with CP
Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy (2019) · Cochrane
no estimate extracted1 study · 26 participantsModerate
BoNT‐A vs serial casting
Observational gait analysis · children with CP
Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy (2019) · Cochrane
no estimate extracted1 study · 18 participantsModerate
BoNT‐A vs serial casting
Function · children with CP
Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy (2019) · Cochrane
no estimate extracted1 study · 18 participantsModerate
BoNT‐A vs usual care or physiotherapy
Spasticity (ankle plantarflexors) · children with CP
Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy (2019) · Cochrane
no estimate extracted2 studies · 186 participantsVery low
BoNT‐A vs serial casting
Range of motion (passive ankle dorsiflexion) · children with CP
Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy (2019) · Cochrane
no estimate extracted2 studies · 44 participantsLow
BoNT‐A vs serial casting
Satisfaction (not measured) · children with CP
Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy (2019) · Cochrane
no estimate extractedNRNo studies
BoNT‐A vs serial casting
Spasticity (ankle plantarflexors) · children with CP
Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy (2019) · Cochrane
no estimate extracted2 studies · 44 participantsLow
BoNT‐A vs serial casting
Adverse events · children with CP
Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy (2019) · Cochrane
no estimate extractedNRNo studies
BoNT‐A vs orthoses
Instrumented gait analysis (not reported) · children with CP
Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy (2019) · Cochrane
no estimate extractedNRNo studies
BoNT‐A vs orthoses
Observational gait analysis (not reported) · children with CP
Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy (2019) · Cochrane
no estimate extractedNRNo studies
BoNT‐A vs orthoses
Function · children with CP
Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy (2019) · Cochrane
no estimate extracted1 study · 43 participantsVery low
BoNT‐A vs orthoses
Range of motion (passive hip abduction) · children with CP
Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy (2019) · Cochrane
no estimate extracted1 study · 43 participantsVery low
BoNT‐A vs orthoses
Satisfaction (not reported) · children with CP
Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy (2019) · Cochrane
no estimate extractedNRNo studies
BoNT‐A vs orthoses
Spasticity (hip adductors) · children with CP
Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy (2019) · Cochrane
no estimate extracted1 study · 43 participantsVery low
BoNT‐A vs usual care or physiotherapy
Adverse events · children with CP
Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy (2019) · Cochrane
no estimate extracted5 studies · 206 participantsVery low
BoNT‐A vs orthoses
Adverse events (not reported) · children with CP
Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy (2019) · Cochrane
no estimate extractedNRNo studies
BoNT‐A vs usual care or physiotherapy
Instrumented gait analysis (kinematics) (not measured) · children with CP
Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy (2019) · Cochrane
no estimate extractedNRNo studies
BoNT‐A vs usual care or physiotherapy
Observational gait analysis · children with CP
Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy (2019) · Cochrane
no estimate extracted1 study · 40 participantsVery low
Constraint induced movement therapy (CIMT) vs low‐dose comparison
Bimanual performance · children with unilateral cerebral palsy
Constraint‐induced movement therapy in children with unilateral cerebral palsy (2019) · Cochrane
no estimate extracted2 studies · 39 participantsLow
Constraint induced movement therapy (CIMT) vs high‐dose comparison
Unimanual capacity · children with unilateral cerebral palsy
Constraint‐induced movement therapy in children with unilateral cerebral palsy (2019) · Cochrane
no estimate extracted1 study · 34 participantsVery low
Constraint induced movement therapy (CIMT) vs high‐dose comparison
Manual ability ‐ not measured · children with unilateral cerebral palsy
Constraint‐induced movement therapy in children with unilateral cerebral palsy (2019) · Cochrane
no estimate extractedNRNo studies
Constraint induced movement therapy (CIMT) vs high‐dose comparison
Self‐care · children with unilateral cerebral palsy
Constraint‐induced movement therapy in children with unilateral cerebral palsy (2019) · Cochrane
no estimate extracted1 study · 34 participantsVery low
Constraint induced movement therapy (CIMT) vs high‐dose comparison
Individualised measures of performance · children with unilateral cerebral palsy
Constraint‐induced movement therapy in children with unilateral cerebral palsy (2019) · Cochrane
no estimate extracted3 studies · 126 participantsLow
Constraint induced movement therapy (CIMT) vs high‐dose comparison
Adverse events · children with unilateral cerebral palsy
Constraint‐induced movement therapy in children with unilateral cerebral palsy (2019) · Cochrane
no estimate extracted4 studies · 186 participantsUngraded
Constraint induced movement therapy (CIMT) vs dose‐matched comparison
Bimanual performance · children with unilateral cerebral palsy
Constraint‐induced movement therapy in children with unilateral cerebral palsy (2019) · Cochrane
no estimate extracted7 studies · 229 participantsLow
Constraint induced movement therapy (CIMT) vs dose‐matched comparison
Unimanual capacity · children with unilateral cerebral palsy
Constraint‐induced movement therapy in children with unilateral cerebral palsy (2019) · Cochrane
no estimate extracted6 studies · 203 participantsLow
Constraint induced movement therapy (CIMT) vs dose‐matched comparison
Unimanual capacity · children with unilateral cerebral palsy
Constraint‐induced movement therapy in children with unilateral cerebral palsy (2019) · Cochrane
no estimate extracted3 studies · 124 participantsVery low
Constraint induced movement therapy (CIMT) vs dose‐matched comparison
Manual ability · children with unilateral cerebral palsy
Constraint‐induced movement therapy in children with unilateral cerebral palsy (2019) · Cochrane
no estimate extracted3 studies · 95 participantsVery low
Constraint induced movement therapy (CIMT) vs dose‐matched comparison
Self‐care · children with unilateral cerebral palsy
Constraint‐induced movement therapy in children with unilateral cerebral palsy (2019) · Cochrane
no estimate extracted2 studies · 45 participantsLow
Constraint induced movement therapy (CIMT) vs low‐dose comparison
Unimanual capacity · children with unilateral cerebral palsy
Constraint‐induced movement therapy in children with unilateral cerebral palsy (2019) · Cochrane
no estimate extracted1 study · 23 participantsVery low
Constraint induced movement therapy (CIMT) vs dose‐matched comparison
Individualised measures of performance · children with unilateral cerebral palsy
Constraint‐induced movement therapy in children with unilateral cerebral palsy (2019) · Cochrane
no estimate extracted6 studies · 191 participantsVery low
Constraint induced movement therapy (CIMT) vs dose‐matched comparison
Adverse events · children with unilateral cerebral palsy
Constraint‐induced movement therapy in children with unilateral cerebral palsy (2019) · Cochrane
no estimate extracted15 studies · 569 participantsUngraded
Constraint induced movement therapy (CIMT) vs different forms CIMT
Bimanual performance · children with unilateral cerebral palsy
Constraint‐induced movement therapy in children with unilateral cerebral palsy (2019) · Cochrane
no estimate extracted2 studies · 60 participantsVery low
Constraint induced movement therapy (CIMT) vs different forms CIMT
Bimanual performance · children with unilateral cerebral palsy
Constraint‐induced movement therapy in children with unilateral cerebral palsy (2019) · Cochrane
no estimate extracted2 studies · 60 participantsVery low
Constraint induced movement therapy (CIMT) vs different forms CIMT
Unimanual capacity ‐ not measured · children with unilateral cerebral palsy
Constraint‐induced movement therapy in children with unilateral cerebral palsy (2019) · Cochrane
no estimate extractedNRNo studies
Constraint induced movement therapy (CIMT) vs different forms CIMT
Unimanual capacity · children with unilateral cerebral palsy
Constraint‐induced movement therapy in children with unilateral cerebral palsy (2019) · Cochrane
no estimate extracted1 study · 60 participantsVery low
Constraint induced movement therapy (CIMT) vs different forms CIMT
Manual Ability ‐ not measured · children with unilateral cerebral palsy
Constraint‐induced movement therapy in children with unilateral cerebral palsy (2019) · Cochrane
no estimate extractedNRNo studies
Constraint induced movement therapy (CIMT) vs different forms CIMT
Self‐care ‐ not measured · children with unilateral cerebral palsy
Constraint‐induced movement therapy in children with unilateral cerebral palsy (2019) · Cochrane
no estimate extractedNRNo studies